214 related articles for article (PubMed ID: 34278478)
1. Interactions between the ERK1/2 signaling pathway and PCAF play a key role in PE‑induced cardiomyocyte hypertrophy.
Mao Q; Wu S; Peng C; Peng B; Luo X; Huang L; Zhang H
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278478
[TBL] [Abstract][Full Text] [Related]
2. JNK signaling-dependent regulation of histone acetylation are involved in anacardic acid alleviates cardiomyocyte hypertrophy induced by phenylephrine.
Peng B; Peng C; Luo X; Wu S; Mao Q; Zhang H; Han X
PLoS One; 2021; 16(12):e0261388. PubMed ID: 34914791
[TBL] [Abstract][Full Text] [Related]
3. Anacardic acid attenuates pressure-overload cardiac hypertrophy through inhibiting histone acetylases.
Li S; Peng B; Luo X; Sun H; Peng C
J Cell Mol Med; 2019 Apr; 23(4):2744-2752. PubMed ID: 30712293
[TBL] [Abstract][Full Text] [Related]
4. Phenylephrine-induced cardiac hypertrophy is attenuated by a histone acetylase inhibitor anacardic acid in mice.
Peng C; Luo X; Li S; Sun H
Mol Biosyst; 2017 Mar; 13(4):714-724. PubMed ID: 28194469
[TBL] [Abstract][Full Text] [Related]
5. Alcohol-induced histone H3K9 hyperacetylation and cardiac hypertrophy are reversed by a histone acetylases inhibitor anacardic acid in developing murine hearts.
Peng C; Zhang W; Zhao W; Zhu J; Huang X; Tian J
Biochimie; 2015 Jun; 113():1-9. PubMed ID: 25797917
[TBL] [Abstract][Full Text] [Related]
6. The Ras-ERK1/2 signaling pathway regulates H3K9ac through PCAF to promote the development of pancreatic cancer.
Li YH; Li YX; Li M; Song SW; Ge Y; Jin JY; Li XY; Tan XD; Ye J
Life Sci; 2020 Sep; 256():117936. PubMed ID: 32531376
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent Effects of PRC2 and HDAC Inhibitors on Cardiomyocyte Hypertrophy Induced by Phenylephrine.
Zhao Z; Lv J; Guo N; Guo Q; Zeng S; Fang Y; Chen W; Wang Z
Curr Drug Targets; 2023; 24(4):371-378. PubMed ID: 36734909
[TBL] [Abstract][Full Text] [Related]
8. Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1/2.
Dong B; Xue R; Sun Y; Dong Y; Liu C
Mol Cell Biochem; 2017 Sep; 433(1-2):113-123. PubMed ID: 28497371
[TBL] [Abstract][Full Text] [Related]
9. Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy.
Yue TL; Gu JL; Wang C; Reith AD; Lee JC; Mirabile RC; Kreutz R; Wang Y; Maleeff B; Parsons AA; Ohlstein EH
J Biol Chem; 2000 Dec; 275(48):37895-901. PubMed ID: 10984495
[TBL] [Abstract][Full Text] [Related]
10. Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.
Sunagawa Y; Shimizu K; Katayama A; Funamoto M; Shimizu K; Nurmila S; Shimizu S; Miyazaki Y; Katanasaka Y; Hasegawa K; Morimoto T
J Pharmacol Sci; 2021 Oct; 147(2):169-175. PubMed ID: 34384564
[TBL] [Abstract][Full Text] [Related]
11. Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy.
Zhong L; Chiusa M; Cadar AG; Lin A; Samaras S; Davidson JM; Lim CC
Cardiovasc Res; 2015 May; 106(2):261-71. PubMed ID: 25770146
[TBL] [Abstract][Full Text] [Related]
12. Effects of ERK1/2/PPARα/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine.
Huang Q; Huang J; Zeng Z; Luo J; Liu P; Chen S; Liu B; Pan X; Zang L; Zhou S
Life Sci; 2015 Mar; 124():41-9. PubMed ID: 25636810
[TBL] [Abstract][Full Text] [Related]
13. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
[TBL] [Abstract][Full Text] [Related]
14. Alcohol exposure increases the expression of cardiac transcription factors through ERK1/2-mediated histone3 hyperacetylation in H9c2 cells.
Gao W; Pan B; Liu L; Huang X; Liu Z; Tian J
Biochem Biophys Res Commun; 2015 Oct; 466(4):670-5. PubMed ID: 26392309
[TBL] [Abstract][Full Text] [Related]
15. Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation.
Jin Q; Yu LR; Wang L; Zhang Z; Kasper LH; Lee JE; Wang C; Brindle PK; Dent SY; Ge K
EMBO J; 2011 Jan; 30(2):249-62. PubMed ID: 21131905
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of histone H3K9 acetylation by anacardic acid can correct the over-expression of Gata4 in the hearts of fetal mice exposed to alcohol during pregnancy.
Peng C; Zhu J; Sun HC; Huang XP; Zhao WA; Zheng M; Liu LJ; Tian J
PLoS One; 2014; 9(8):e104135. PubMed ID: 25101666
[TBL] [Abstract][Full Text] [Related]
17. DEF6(differentially exprehomolog) exacerbates pathological cardiac hypertrophy via RAC1.
Sun Y; Xu C; Jiang Z; Jiang X
Cell Death Dis; 2023 Jul; 14(7):483. PubMed ID: 37524688
[TBL] [Abstract][Full Text] [Related]
18. Nε-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heart.
Colussi C; Rosati J; Straino S; Spallotta F; Berni R; Stilli D; Rossi S; Musso E; Macchi E; Mai A; Sbardella G; Castellano S; Chimenti C; Frustaci A; Nebbioso A; Altucci L; Capogrossi MC; Gaetano C
Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2795-800. PubMed ID: 21282606
[TBL] [Abstract][Full Text] [Related]
19. GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK/p38 signaling pathway.
Li J; Yan C; Wang Y; Chen C; Yu H; Liu D; Huang K; Han Y
Cell Death Dis; 2022 Apr; 13(4):421. PubMed ID: 35490166
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine phosphorylation of RACK1 triggers cardiomyocyte hypertrophy by regulating the interaction between p300 and GATA4.
Suzuki H; Katanasaka Y; Sunagawa Y; Miyazaki Y; Funamoto M; Wada H; Hasegawa K; Morimoto T
Biochim Biophys Acta; 2016 Sep; 1862(9):1544-57. PubMed ID: 27208796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
